India's TDB backs Peptris with ₹86 crore for AI-driven drug development

Oct 12, 2026 · Issue 11 · 4 sources, 4 articles

The Technology Development Board (TDB) approved ₹86 crore in support for four AI-discovered drug candidates from Peptris. Another report says India's drug discovery push will be tested by human trials.

Who is affected and how

pharmaceuticals

If Indian AI-based candidates reach clinical phases, it could show how much cheaper discovery is actually worth.

Sources

• TDB approves ₹86 crore RDI support for Peptris’ AI-driven drug development - Express Pharmaexpresspharma.in · Oct 12, 2026
• TDB backs Peptris with Rs 86 crore to advance four AI-discovered drug candidates - The HinduBusinessLinethehindubusinessline.com · Oct 12, 2026
• ‘AI lowers the capital needed’: India’s drug discovery push faces test of human trials - CNAchannelnewsasia.com · Oct 15, 2026
• ‘AI lowers the capital needed’: India’s drug discovery push faces test of human trialscna · Oct 16, 2026

Machine-generated summary based on the titles and excerpts of the source articles. The source article is the authority for the facts. News monitoring, not medical advice: consult a doctor for health decisions.